Fuglesang Christopher

CIK 00014658353 companiesSOLANA BEACH, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001465835

Recent Transactions

44 trades

Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−3,201,440→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−30,518→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−287,866→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−3,578,036→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−203,754→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−3,135,966→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−332,809→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2024-01-23−1,413,475→ 0 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2023-08-11$27.80/sh+57,533→ 287,866 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2023-08-11$27.80/sh+1,201,440→ 3,201,440 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2023-08-11$27.80/sh+57,533→ 287,866 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2023-08-11$27.80/sh+1,201,440→ 3,201,440 total
Disposition from Tender
Pandion Therapeutics, Inc.
Common Stock
2021-04-01$60.00/sh−2,107,513→ 0 total
Disposition to Issuer
Pandion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-04-01−13,997→ 0 total
Disposition from Tender
Pandion Therapeutics, Inc.
Common Stock
2021-04-01$60.00/sh−23,622→ 0 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$181.00/sh−1→ 267,333 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$0.00/sh+13,996→ 267,334 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$181.00/sh−4→ 2,363,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$181.15/sh−37,000→ 230,333 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$181.15/sh−363,000→ 2,000,000 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-03-05$0.00/sh+597,444→ 2,363,004 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2021-03-05$5.60/sh−128,805→ 0 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2021-03-05$5.60/sh−13,996→ 0 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2021-03-05$13.00/sh−468,639→ 332,809 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$202.00/sh−37,050→ 216,288 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$202.00/sh−362,950→ 1,404,610 total
Tax Payment
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$219.97/sh−2→ 1,765,560 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2020-10-30$5.60/sh−37,051→ 13,996 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$0.00/sh+37,051→ 253,339 total
Tax Payment
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$219.97/sh−1→ 253,338 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2020-10-30$0.00/sh+362,952→ 1,765,562 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2020-10-30$5.60/sh−362,952→ 128,805 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+1,408,913→ 1,408,913 total
Conversion
Pandion Therapeutics, Inc.
Series B Preferred Stock
2020-07-21−7,184,596→ 0 total
Purchase
Pandion Therapeutics, Inc.
Common Stock
2020-07-21$18.00/sh+722,222→ 2,600,773 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+13,997→ 13,997 total
Exercise of In-Money
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2017-10-03−78,186→ 0 total
Exercise of In-Money
Mirati Therapeutics, Inc.
Common Stock
2017-10-03$7.86/sh+189,780→ 1,227,774 total
Exercise of In-Money
Mirati Therapeutics, Inc.
Common Stock
2017-10-03$7.86/sh+78,186→ 513,630 total
Exercise of In-Money
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2017-10-03−189,780→ 0 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2017-01-06$5.60/sh+6,104→ 435,444 total
Purchase
Mirati Therapeutics, Inc.
Common Stock
2017-01-06$5.60/sh+280,059→ 1,037,994 total
Purchase
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2017-01-06$5.60/sh+51,047→ 51,047 total
Purchase
Mirati Therapeutics, Inc.
Warrant (right to purchase)
2017-01-06$5.60/sh+2,341,786→ 2,341,786 total

Companies

Recent Filings

Address

440 STEVENS AVE, SUITE 100

SOLANA BEACH, CA, 92075

View on SEC.gov